Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation : Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved..
The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here we report our recommendations regarding detection of the multidrug-resistant bacteria in hematology.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
---|---|
Enthalten in: |
Bulletin du cancer - 107(2020), 1S vom: 15. Jan., Seite S7-S11 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Dépistage des bactéries multirésistantes (BMR) et hautement résistantes émergentes (BHRe) aux antibiotiques en allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
---|
Beteiligte Personen: |
Brissot, Eolia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Allogeneic stem cell transplantation |
---|
Anmerkungen: |
Date Completed 03.03.2020 Date Revised 03.03.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bulcan.2019.09.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM302419829 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM302419829 | ||
003 | DE-627 | ||
005 | 20231225110704.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/j.bulcan.2019.09.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1008.xml |
035 | |a (DE-627)NLM302419829 | ||
035 | |a (NLM)31635753 | ||
035 | |a (PII)S0007-4551(19)30349-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Brissot, Eolia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation |b Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
246 | 3 | 3 | |a Dépistage des bactéries multirésistantes (BMR) et hautement résistantes émergentes (BHRe) aux antibiotiques en allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.03.2020 | ||
500 | |a Date Revised 03.03.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved. | ||
520 | |a The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here we report our recommendations regarding detection of the multidrug-resistant bacteria in hematology | ||
650 | 4 | |a Consensus Development Conference | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Practice Guideline | |
650 | 4 | |a Review | |
650 | 4 | |a Allogeneic stem cell transplantation | |
650 | 4 | |a BHRe | |
650 | 4 | |a BMR | |
650 | 4 | |a Hématologie | |
650 | 4 | |a Multidrug-resistant bacteria | |
700 | 1 | |a Villate, Alban |e verfasserin |4 aut | |
700 | 1 | |a Alsuliman, Tamim |e verfasserin |4 aut | |
700 | 1 | |a Beauvais, David |e verfasserin |4 aut | |
700 | 1 | |a Bonnin, Agnès |e verfasserin |4 aut | |
700 | 1 | |a Mear, Jean-Baptiste |e verfasserin |4 aut | |
700 | 1 | |a Souchet, Laetitia |e verfasserin |4 aut | |
700 | 1 | |a Yakoub-Agha, Ibrahim |e verfasserin |4 aut | |
700 | 1 | |a Bazarbachi, Ali |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 107(2020), 1S vom: 15. Jan., Seite S7-S11 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
773 | 1 | 8 | |g volume:107 |g year:2020 |g number:1S |g day:15 |g month:01 |g pages:S7-S11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bulcan.2019.09.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 107 |j 2020 |e 1S |b 15 |c 01 |h S7-S11 |